PATENT CLAIM ANALYSIS

Application Number: 16184466
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-02
Patent Classification: ["424", "093200"]

Abstract:
The disclosure relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides encoding AADC for the treatment of Parkinson's Disease.

Claim (Index 3):
The AADC polynucleotide of  claim 2 , wherein the AADC sequence region comprises at least one 5\u2032 inverted terminal repeat (ITR) region and one 3\u2032 ITR region.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 98.0
- Lexical Diversity: 1.17391
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15524986', '16302146', '15191357', '15209363', '13647155']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6888379652670793
- 35 USC 102 Novelty (BERT): 0.4994855777519357
- Combined Prediction Score: 0.6699027265155649
- Mean Citation Score: 233.923604
- Max Citation Score: 283.63107
- Similarity Product: 255.80129818170903

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test